Evidence map›Paper›PMID 26778482›Full record

ArticleMolecular nutrition & food research2016

L-cysteine supplementation upregulates glutathione (GSH) and vitamin D binding protein (VDBP) in hepatocytes cultured in high glucose and in vivo in liver, and increases blood levels of GSH, VDBP, and 25-hydroxy-vitamin D in Zucker diabetic fatty rats.

Sushil K Jain, Preeti Kanikarla-Marie, Cassandra Warden, David Micinski

Open access · hybridAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Unravelling the Therapeutic Potential of Cysteine for Cardiovascular Health.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Protective Effect ofNutrients · 2021
    Article
  9. Review
  10. Relevance of vitamin DGene reports · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The possible benefits of vitamin D in COVID-19.Nutrition (Burbank, Los Angeles County, Calif.)
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sushil K JainDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA.
Preeti Kanikarla-MarieDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA.
Cassandra WardenDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA.
David MicinskiDepartment of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, 71130, USA.
Louisiana State University Health Sciences Center Shreveport · US

Funding

L-cysteine, PIP3 and Insulin Signaling in DiabetesR01AT007442 · NCCIH · LOUISIANA STATE UNIV HSC SHREVEPORT · PI JAIN, SUSHIL K · 2014 to 2015
$643k
NCCIH NIH HHS R01 AT007442
6 · The paper itself

Abstract

scopeVitamin D binding protein (VDBP) status has an effect on and can potentially improve the status of 25(OH) vitamin D and increase the metabolic actions of 25(OH) vitamin D under physiological and pathological conditions. Diabetes is associated with lower levels of glutathione (GSH) and 25(OH) vitamin D. This study examined the hypothesis that upregulation of GSH will also upregulate blood levels of VDBP and 25(OH) vitamin D in type 2 diabetic rats. METHODS AND

resultsL-cysteine (LC) supplementation was used to upregulate GSH status in a FL83B hepatocyte cell culture model and in vivo using Zucker diabetic fatty (ZDF) rats. Results show that LC supplementation upregulates both protein and mRNA expression of VDBP and vitamin D receptor (VDR) and GSH status in hepatocytes exposed to high glucose, and that GSH deficiency, induced by glutamate cysteine ligase knockdown, resulted in the downregulation of GSH, VDBP, and VDR and an increase in oxidative stress levels in hepatocytes. In vivo, LC supplementation increased GSH and protein and mRNA expression of VDBP and vitamin D 25-hydroxylase (CYP2R1) in the liver, and simultaneously resulted in elevated blood levels of LC and GSH, as well as increases in VDBP and 25(OH) vitamin D levels, and decreased inflammatory biomarkers in ZDF rats compared with those in placebo-supplemented ZDF rats consuming a similar diet.

conclusionLC supplementation may provide a novel approach by which to raise blood levels of VDBP and 25(OH) vitamin D in type 2 diabetes.

Indexed as

AnimalsBiomarkersCell LineCulture MediaCysteineDiabetes Mellitus, ExperimentalDietary SupplementsGene Expression RegulationGlucoseGlutamate-Cysteine LigaseGlutathioneHepatocytesLiverMaleMiceOxidative Stress25-hydroxyvitamin DBiomarkersCulture MediaCysteineGCLC protein, ratGlucoseGlutamate-Cysteine LigaseGlutathioneVitamin DVitamin D-Binding ProteinCYP2R1, DGSHHepatocytesL-cysteineType 2 diabetesVDBPVitamin

Identifiers

PMID26778482
PMCPMC4876732
OpenAlexW2254167756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.